# Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or m

> **NCT00997230** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 4243 (actual)

## Conditions studied

- Newly Diagnosed Locally Advanced or Metastatic Non-small Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00997230
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 4243 (ACTUAL)
- **Last updated:** 2013-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997230, "Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or m". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00997230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*